Chronic refractory osteomyelitis is a persistent bone infection that does not respond adequately to conventional treatments such as long-term antibiotics and surgical debridement. The condition can be difficult to eradicate due to poor blood supply within infected bone, making it challenging for antibiotics and immune cells to reach the affected area. In selected cases, Hyperbaric Oxygen Therapy (HBOT) is used as an adjunctive treatment to support infection control and promote bone healing. HBOT enhances oxygen delivery to infected tissues, helping to overcome the limitations of compromised circulation that often underpin treatment failure.
Understanding Chronic Refractory Osteomyelitis
Osteomyelitis occurs when bacteria or, less commonly, fungi infect bone tissue. When the infection becomes chronic, it may persist for months or years despite repeated courses of antibiotics and surgical intervention. Refractory cases are often associated with:
- Previous trauma or open fractures
- Orthopaedic implants or prosthetic material
- Diabetes or peripheral vascular disease
- Reduced local blood flow
- Recurrent or incomplete surgical clearance
Chronic infection can lead to bone destruction, ongoing pain, draining sinuses, reduced mobility, and a significant impact on quality of life.
Why HBOT Is Used in Refractory Bone Infections
Hyperbaric Oxygen Therapy targets several key factors that contribute to persistent infection. Mechanisms of Action 1. Improves Oxygenation of Infected Bone HBOT increases the amount of oxygen dissolved in plasma, allowing oxygen to reach areas of bone with poor vascular supply. 2. Enhances Antibiotic Effectiveness Many antibiotics rely on adequate oxygen levels to work effectively. HBOT can improve their bactericidal activity, particularly against aerobic organisms. 3. Supports Immune Function Oxygen-rich environments enhance white blood cell activity, improving the body’s ability to combat infection. 4. Promotes Bone and Soft Tissue Healing HBOT stimulates angiogenesis (new blood vessel formation) and supports bone remodelling and soft tissue repair.
HBOT as Part of a Combined Treatment Strategy
HBOT is not used in isolation for chronic osteomyelitis. It is typically introduced alongside:
- Targeted, long-term antibiotic therapy
- Surgical debridement of infected or necrotic bone
- Wound management and reconstruction where required
Treatment plans are individualised, and patients may undergo multiple hyperbaric sessions over several weeks as part of a coordinated care pathway.
HBOT in UK Clinical Practice
In the UK, HBOT for refractory osteomyelitis is delivered through accredited hyperbaric centres following referral from orthopaedic surgeons or infectious disease specialists. Treatment follows recognised clinical indications and is provided under specialist medical supervision, with careful monitoring throughout the course.
Clinical Outcomes and Recovery
When used appropriately, HBOT may contribute to:
- Improved infection control
- Reduced recurrence rates
- Enhanced bone healing
- Decreased need for repeated surgery
- Preservation of limb function
Outcomes depend on factors such as infection severity, patient health, surgical success, and adherence to antibiotic regimens.
FAQs About Chronic Refractory Osteomyelitis and HBOT
It is considered refractory when infection persists despite adequate antibiotic therapy and surgical management.
No. HBOT supports but does not replace standard treatments.
Courses often involve multiple sessions over several weeks, depending on response and clinical guidance.
Yes. HBOT is generally well tolerated when delivered in a controlled clinical setting.
HBOT is most effective in carefully selected chronic, treatment-resistant cases.
Conclusion
Chronic refractory osteomyelitis presents significant clinical challenges due to poor bone vascularity and persistent infection. Hyperbaric Oxygen Therapy offers a valuable adjunctive approach by improving oxygen delivery, enhancing immune response, and supporting bone healing. When integrated into a multidisciplinary treatment plan, HBOT can help improve outcomes and reduce the long-term burden of this difficult condition.